Yorktown Management & Research Co Inc Takes Position in Integer Holdings Corporation (NYSE:ITGR)

Yorktown Management & Research Co Inc bought a new stake in Integer Holdings Corporation (NYSE:ITGR - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 2,350 shares of the medical equipment provider's stock, valued at approximately $277,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Capital Research Global Investors boosted its stake in shares of Integer by 16.0% in the fourth quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider's stock valued at $186,960,000 after purchasing an additional 194,895 shares during the period. Loomis Sayles & Co. L P lifted its holdings in Integer by 3.8% during the 4th quarter. Loomis Sayles & Co. L P now owns 558,715 shares of the medical equipment provider's stock worth $74,041,000 after buying an additional 20,688 shares in the last quarter. Congress Asset Management Co. lifted its holdings in Integer by 4.9% during the 1st quarter. Congress Asset Management Co. now owns 522,656 shares of the medical equipment provider's stock worth $61,679,000 after buying an additional 24,306 shares in the last quarter. Driehaus Capital Management LLC boosted its position in Integer by 5.5% in the 4th quarter. Driehaus Capital Management LLC now owns 451,464 shares of the medical equipment provider's stock valued at $59,828,000 after buying an additional 23,706 shares during the period. Finally, Northern Trust Corp grew its stake in shares of Integer by 14.2% in the fourth quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider's stock worth $55,974,000 after acquiring an additional 52,556 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Integer Stock Up 0.2%

ITGR stock traded up $0.27 during trading on Wednesday, hitting $120.69. 476,709 shares of the company's stock were exchanged, compared to its average volume of 381,539. The business has a 50-day moving average price of $119.99 and a two-hundred day moving average price of $126.41. The company has a current ratio of 3.40, a quick ratio of 2.14 and a debt-to-equity ratio of 0.78. The stock has a market capitalization of $4.21 billion, a price-to-earnings ratio of 57.20, a PEG ratio of 1.02 and a beta of 0.98. Integer Holdings Corporation has a 52-week low of $104.93 and a 52-week high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. Integer had a net margin of 4.38% and a return on equity of 11.95%. The company's revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.14 EPS. As a group, equities research analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of Integer stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the transaction, the chief executive officer now directly owns 47,000 shares of the company's stock, valued at $5,788,990. The trade was a 87.82% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Donald J. Spence sold 14,739 shares of the firm's stock in a transaction on Wednesday, June 4th. The stock was sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the transaction, the director now directly owns 18,781 shares in the company, valued at $2,260,856.78. The trade was a 43.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 362,434 shares of company stock valued at $44,577,115. 2.16% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on ITGR shares. KeyCorp reduced their price objective on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Raymond James Financial increased their price target on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, April 25th. Citigroup raised Integer from a "hold" rating to a "strong-buy" rating and boosted their price objective for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Benchmark cut their target price on shares of Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Finally, Truist Financial set a $150.00 target price on shares of Integer and gave the company a "buy" rating in a report on Friday, April 25th. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $145.00.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.